CN101293056A - Medicament for preventing and treating near-sightedness - Google Patents
Medicament for preventing and treating near-sightedness Download PDFInfo
- Publication number
- CN101293056A CN101293056A CNA2008101237428A CN200810123742A CN101293056A CN 101293056 A CN101293056 A CN 101293056A CN A2008101237428 A CNA2008101237428 A CN A2008101237428A CN 200810123742 A CN200810123742 A CN 200810123742A CN 101293056 A CN101293056 A CN 101293056A
- Authority
- CN
- China
- Prior art keywords
- gram
- drug
- treatment
- medicine
- myopia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 230000004379 myopia Effects 0.000 title abstract description 11
- 208000001491 myopia Diseases 0.000 title abstract description 11
- 241000978093 Metaplexis Species 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 240000001592 Amaranthus caudatus Species 0.000 claims description 6
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims description 6
- 235000012735 amaranth Nutrition 0.000 claims description 6
- 239000004178 amaranth Substances 0.000 claims description 6
- 150000002333 glycines Chemical class 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 11
- 230000004438 eyesight Effects 0.000 abstract description 7
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 244000237956 Amaranthus retroflexus Species 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 241001533104 Tribulus terrestris Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 244000257022 tick clover Species 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 241000909851 Epiphora Species 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000009978 visual deterioration Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XQJMXPAEFMWDOZ-UHFFFAOYSA-N 3exo-benzoyloxy-tropane Natural products CN1C(C2)CCC1CC2OC(=O)C1=CC=CC=C1 XQJMXPAEFMWDOZ-UHFFFAOYSA-N 0.000 description 1
- 201000009487 Amblyopia Diseases 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- QQXLDOJGLXJCSE-UHFFFAOYSA-N N-methylnortropinone Natural products C1C(=O)CC2CCC1N2C QQXLDOJGLXJCSE-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- QIZDQFOVGFDBKW-DHBOJHSNSA-N Pseudotropine Natural products OC1C[C@@H]2[N+](C)[C@H](C1)CC2 QIZDQFOVGFDBKW-DHBOJHSNSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- YTLQFZVCLXFFRK-UHFFFAOYSA-N bendazol Chemical compound N=1C2=CC=CC=C2NC=1CC1=CC=CC=C1 YTLQFZVCLXFFRK-UHFFFAOYSA-N 0.000 description 1
- 229950000900 bendazol Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- ALWKGYPQUAPLQC-UHFFFAOYSA-N neostigmine Chemical compound CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 ALWKGYPQUAPLQC-UHFFFAOYSA-N 0.000 description 1
- 229960002362 neostigmine Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- CYHOMWAPJJPNMW-JIGDXULJSA-N tropine Chemical compound C1[C@@H](O)C[C@H]2CC[C@@H]1N2C CYHOMWAPJJPNMW-JIGDXULJSA-N 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for prevention and treatment of myopia, which is prepared by Chinese herbal medicines. The drug is characterized in that the drug comprises the medicines with the following weight: 30 to 70g of dream flower, 20 to 40g of puncturevine caltrop fruit, 70 to 130g of cicada slough, 10 to 30g of amur corktree bark, 30 to 70g of wild amaranth, 70 to 130g of seed of wild groundnut and 40 to 60g of Japanese metaplexis pericarp. The whole formula has perfect compatibility, powerful drug efficacy and orderly sequence, which can hit the disease mechanism and fully reflect the treatment principles of clearing heat, removing toxin, dispelling pathogenic wind, removing dampness, activating blood circulation, resolving phlegm, improving eyesight, eliminating eye screens and invigorating liver and kidney.
Description
Technical field
The present invention relates to a kind of bathomorphic medicine that prevents and treat, particularly utilize Chinese herbal medicine to make the bathomorphic medicine of control.
Background technology
Myopia is people's common frdquently encountered diseases, result according to national physical health of students investigation in 1996 shows, China's myopia of student incidence rate is a primary school 22.78%, middle school 55.22%, university 76.74%, along with TV, computer popularization and application, and the pollution of environment, the minimizing of outdoor activity, this ratio are also being risen year by year.Myopia is because light is injected ophthalmic, dioptric system flexion through eye, the burnt one-tenth of collection focus drops on amphiblestroid front, therefore similarly be unsharp on the retina, it and heredity, environment, long-term close eye is relevant, the traditional Chinese medical science is thought myopia and liver, kidney, spleen loss and wind, fire, wet, the expectorant heap soil or fertilizer over and around the roots hinders muscle venation near the eyes, eye loses QI and blood and moistens foster, cause a regulating action to weaken and cause visual deterioration, myopia not only influences work and study, also to choosing spouse, choose a job, instrument has certain influence, the rectification way gets the right lensses for one's eyeglasses at present, doctor trained in Western medicine adopts medicine that neostigmine is arranged, the card product, bendazol, medicine and some therapeutic appliance such as general Shandong tropine, this type of treatment has only short run effect, the traditional Chinese medical science adopts acupuncture-moxibustion massage and Radix Salviae Miltiorrhizae Tabellae, medicines such as cod-liver oil, it is little that Chinese and Western medicine is compared apparent side effect, curative effect is lasting, characteristics such as therapeutic effect is good, as the Herba Dendrobii soft extract is exactly a kind of reasonable medicine, its Main Ingredients and Appearance is: Herba Dendrobii, Radix Ginseng, Radix Asparagi, Poria, the Radix Rehmanniae, Radix Rehmanniae Preparata, Radix Ophiopogonis, Flos Chrysanthemi, Semen Cuscutae, Semen Armeniacae Amarum, Radix Achyranthis Bidentatae, Fructus Schisandrae Chinensis, Fructus Tribuli, Rhizoma Dioscoreae, Herba Cistanches, Rhizoma Chuanxiong, Fructus Aurantii, Radix Saposhnikoviae, Rhizoma Coptidis, Semen Celosiae, Radix Glycyrrhizae, Fructus Lycii, medicines such as Semen Cassiae are formed, and it is many to exist flavour of a drug in actual the use, the shortcoming that curative effect is low.
Summary of the invention
Purpose of the present invention is exactly the shortcoming that prior art exists, and a kind of have medicine 5 compatibility refines, the bathomorphic medicine of the control that therapeutic effect is good are provided.
For achieving the above object, the present invention has adopted following technical scheme:
A kind ofly prevent and treat bathomorphic medicine, it is characterized in that it contains the material medicine of following weight: Flos edgeworthiae 30-70 gram, Fructus Tribuli 20-40 gram, Periostracum Cicadae 70-130 gram, Cortex Phellodendri 10-30 gram, wild edible amaranth 30-70 gram, Semen glycines sojae 70-130 gram, Pericarpium Metaplexis 40-60 gram.
Realize preferred plan of the present invention by component weight:
Flos edgeworthiae 350 grams, Fructus Tribuli 30 grams, Periostracum Cicadae 100 grams, Cortex Phellodendri 20 grams, wild edible amaranth 50 grams, Pericarpium Metaplexis 50 grams.
Chinese medicinal preparation method of the present invention is:
Flos edgeworthiae, Fructus Tribuli, Periostracum Cicadae, Cortex Phellodendri, wild edible amaranth, Pericarpium Metaplexis is selected, dry, pulverize, be mixed, cross 100 mesh sieves and become the fineness powder, behind sterilization, incapsulate, every powder charge powder 0.35 gram is finished product.
The effect achievement:
The present invention prevention and treat each Chinese medicine component in bathomorphic Chinese medicine and preparation method thereof: Periostracum Cicadae, Cortex Phellodendri, wild edible amaranth three medicines are combined with clearing away heat-fire, the effect of detoxifcation dampness.Fructus Tribuli, Flos edgeworthiae, Pericarpium Metaplexis have promoting the circulation of blood, make eye bright, nebula removing barrier, clears phlegm.Semen glycines sojae has the dispel the wind effect of detoxifcation of liver and kidney tonifying.Therefore the present invention have heat-clearing and toxic substances removing, expelling wind and removing dampness, the function of the expectorant of invigorating blood circulation, the removing nebula that makes eye bright, liver and kidney tonifying.
The present invention compares with the traditional treatment myopia and has the following advantages:
The present invention is a pure Chinese medicinal preparation, has no side effect, and the cure rate height does not have recurrence, and preparation is simple, and medical expense is low.
Chinese medicine of the present invention is suitable for disease: myopia, amblyopia, glaucoma, epiphora induced by wind.
Instructions of taking: oral, every day three times, each 10, eliminating cold for resuscitation water send down, and below 14 years old, body weight is lower than 50 kilograms of consumptions and reduces by half more than 70 years old.
For showing Chinese medicine of the present invention, through 3 routine patient's clinical treatment observations to the myopia therapeutic effect: male's 2 examples, women's 1 example, the age is respectively 67,44,16 years old.
One, diagnostic criteria: according to standard control " visual acuity chart " testing standard.
Two, observational technique: the clinical symptoms performance before and after the contrast therapy.
Three, medication: every day three times, each 10,7 days is a course of treatment, carries out eyesight testing after finishing the course of treatment.Adopt treatment front and back self-controlled method.Treatment phase other Therapeutic Method of stopping using.
Four, curative effect determinate standard
1, cure: clinical symptoms all disappears, and vision reaches in 1.5,1 years and do not recur.
2, produce effects: clinical symptoms disappears more than 70%.
3, effective: clinical symptoms disappears more than 40%.
4, invalid: ratio before and after the treatment, each side does not all have progress.
Five, observe conclusion: cure 3 examples
The specific embodiment
With selected Flos edgeworthiae 50 grams, Fructus Tribuli 30 grams, Periostracum Cicadae 100 grams, Cortex Phellodendri 20 grams, wild edible amaranth 50 grams, Pericarpium Metaplexis 50 gram oven dry, pulverizing, cross 100 mesh sieve mixings, incapsulate after the sterilization, each is by 0.35 gram dress, each 10, every day three times, eliminating cold for resuscitation water send down, and consumption cuts down according to the circumstance more than 70 years old, below 14 years old.
Li Wanyang, the man, 16 years old, eyesight testing 1.2, through three the course of treatment vision restoration to 1.5, coming vision to remain on 1.5. 2 years more
Slander the jasmine duckweed, the woman, 44 years old, ophthalmic pruritus, epiphora induced by wind, visual deterioration, confirm as through this county's county hospital: myopia merges high intraocular pressure, eye dysbolismus, medication vision restoration to 1.5 four courses of treatment, complication all disappears, and does not see recurrence 3 years more.
Claims (1)
- A kind ofly prevent and treat bathomorphic medicine, it is characterized in that it contains the material medicine of following weight: Flos edgeworthiae 30-70 gram, Fructus Tribuli 20-40 gram, Periostracum Cicadae 70-130 gram, Cortex Phellodendri 10-30 gram, wild edible amaranth 30-70 gram, Semen glycines sojae 70-130 gram, Pericarpium Metaplexis 40-60 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101237428A CN101293056B (en) | 2008-06-02 | 2008-06-02 | Medicament for preventing and treating near-sightedness |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101237428A CN101293056B (en) | 2008-06-02 | 2008-06-02 | Medicament for preventing and treating near-sightedness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101293056A true CN101293056A (en) | 2008-10-29 |
| CN101293056B CN101293056B (en) | 2011-09-28 |
Family
ID=40063764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101237428A Active CN101293056B (en) | 2008-06-02 | 2008-06-02 | Medicament for preventing and treating near-sightedness |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101293056B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104939968A (en) * | 2014-01-27 | 2015-09-30 | 罗东海 | Glasses frame type eye disease treating instrument |
| CN106138228A (en) * | 2015-04-20 | 2016-11-23 | 临沂大学 | A kind of method preventing student's pseudomyopia |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1149481A (en) * | 1996-04-16 | 1997-05-14 | 郭良才 | Capsule for enhancing eyesight |
| CN1159936A (en) * | 1997-01-08 | 1997-09-24 | 丁明月 | Medicine for preventing and treating eye diseases |
| CN101085174B (en) * | 2007-06-15 | 2010-05-19 | 张铁牛 | Traditional Chinese medicine oral liquid with kidney-nourishing eyesight-improving and health-care function |
-
2008
- 2008-06-02 CN CN2008101237428A patent/CN101293056B/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104939968A (en) * | 2014-01-27 | 2015-09-30 | 罗东海 | Glasses frame type eye disease treating instrument |
| CN106138228A (en) * | 2015-04-20 | 2016-11-23 | 临沂大学 | A kind of method preventing student's pseudomyopia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101293056B (en) | 2011-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101773653B (en) | Chinese medicine composition for treating ablepsia and preparation method thereof | |
| CN103405728A (en) | Traditional Chinese medicine composition for treating climacteric syndrome and preparation method thereof | |
| CN104706820A (en) | Chinese herbal medicine containing eye-protecting tablet | |
| CN111035748A (en) | Traditional Chinese medicine composition for improving myopia, external application preparation for improving myopia and eye patch for improving myopia | |
| CN1843457A (en) | Oral liquid for promoting eyesight and protecting eye | |
| CN104116900A (en) | Traditional Chinese medicine dressing for preventing and treating myopia and preparation method of traditional Chinese medicine dressing | |
| CN102973683A (en) | Drug for treating proliferation of mammary gland, and preparation method thereof | |
| CN1830480A (en) | Medicine for treating myopia and its preparation method | |
| CN104906220B (en) | A kind of Chinese medicine for treating herpes zoster and herpes simplex keratitis | |
| CN101293056B (en) | Medicament for preventing and treating near-sightedness | |
| CN102579991A (en) | Chinese medicinal inflammation diminishing preparation for treating herpes simplex keratitis | |
| CN109700889A (en) | A kind of Chinese medicine composition and preparation method thereof of health care eyes | |
| CN1160091C (en) | Medicine for treating ophthalmopathy | |
| CN107929670A (en) | A kind of Medicated eye-mask for treating eye-blurred and preparation method thereof | |
| CN104055841B (en) | A kind for the treatment of and pre-myopic-preventing pharmaceutical composition | |
| CN102885957B (en) | Traditional Chinese medicine composition for preventing and treating hypertension and preparation method thereof | |
| CN1218708C (en) | Chinese medicine prescription for curing eye disease and its preparation method | |
| CN104645081A (en) | Traditional Chinese medicine capsules for treating trigeminal neuralgia and preparation method thereof | |
| CN110478442A (en) | A kind of Multifunctional eye drops and preparation method thereof | |
| CN104644747A (en) | Eye compress liquid mainly for treating pseudomyopia | |
| CN102370906B (en) | Traditional Chinese medicinal combination with function of relieving asthenopia and preparation method thereof | |
| CN106491730A (en) | A kind of treat Chinese medicine composition of glaucoma and preparation method thereof | |
| CN104491403A (en) | Medicine for treating central retinochoroiditis and preparation method | |
| CN104524036A (en) | Traditional Chinese medicine preparation for treating optic neuritis and preparation method thereof | |
| CN105168963A (en) | Traditional Chinese medicinal composition for treating xerophthalmia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ma Xilei Inventor before: Li Sanmeng |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180213 Address after: No. 192 Qi Cun village, Qi Cun town, Central District, Zaozhuang City, Shandong Province Patentee after: Ma Xilei Address before: 233336 Anhui province Wuhe County Shuang Zhong Miao Zhen Da Yang Cun fishermen group Patentee before: Li Sanmeng |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180920 Address after: 518000 Tian'an Community, Shatou Street, Futian District, Shenzhen City, Guangdong Province Patentee after: Shenzhen jinshijia Biological Technology Management Co., Ltd. Address before: 277122 Qi Qi Cun 192, Qi Cun town, Shizhong District, Zaozhuang, Shandong Patentee before: Ma Xilei |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190527 Address after: 277110 Qixi Village 383, Qicun Town, Central District, Zaozhuang City, Shandong Province Patentee after: Ma Xilei Address before: 518000 Tian'an Community, Shatou Street, Futian District, Shenzhen City, Guangdong Province Patentee before: Shenzhen jinshijia Biological Technology Management Co., Ltd. |